memo therapeutics · Funding, investors and similar startups

About

The company develops therapeutic antibodies to treat patients with viral infections and cancer using a high-throughput single-cell screening platform.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies

Mémo Tx
The company develops antibody therapeutics for viral infections and cancer to treat patients such as kidney transplant recipients.
ATB Therapeutics
The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.
Solu Therapeutics
This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.
Mestag Therapeutics
This company develops antibody therapies targeting fibroblast immunology for patients with cancer and inflammatory diseases.
CheckmAb
This biotechnology company develops monoclonal antibody therapies for cancer and autoimmune disease patients by targeting regulatory T cells within pathological tissues.
Ancora Biotech
The company develops multi-specific antibody therapeutics to treat patients with cancer, inflammatory disorders, and chronic hepatitis B infections.
AbCellera Biologics
The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.
AbCellera
This company develops antibody discovery technology and therapeutic medicines for biotechnology and pharmaceutical partners to treat cancer, autoimmune disorders and infectious diseases.